AcclaimIP-ad

Match Document Document Title Score
US20140024553 METHODS OF IDENTIFICATION AND DIAGNOSIS OF LUNG DISEASES USING CLASSIFICATION SYSTEMS AND KITS THEREOF  
The invention provides biomarkers and combinations of biomarkers useful in diagnosing lung diseases such as non-smail cell lung cancer or reactive airway disease. Measurements of these biomarkers...
999
WO/2015/066564A1 METHODS OF IDENTIFICATION AND DIAGNOSIS OF LUNG DISEASES USING CLASSIFICATION SYSTEMS AND KITS THEREOF  
The invention provides biomarkers and combinations of biomarkers useful in diagnosing lung diseases such as non-small cell lung cancer or reactive airway disease. Measurements of these biomarkers...
955
WO/2012/149550A1 METHODS OF IDENTIFICATION AND DIAGNOSIS OF LUNG DISEASES USING CLASSIFICATION SYSTEMS AND KITS THEREOF  
The invention provides biomarkers and combinations of biomarkers useful in diagnosing lung diseases such as non-smail cell lung cancer or reactive airway disease. Measurements of these biomarkers...
953
EP2702411A4 METHODS OF IDENTIFICATION AND DIAGNOSIS OF LUNG DISEASES USING CLASSIFICATION SYSTEMS AND KITS THEREOF   743
8541183 Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof  
The invention provides biomarkers and combinations of biomarkers that are useful in diagnosing lung diseases such as non-small cell lung cancer or reactive airway disease. The invention also...
730
EP2702411A1 METHODS OF IDENTIFICATION AND DIAGNOSIS OF LUNG DISEASES USING CLASSIFICATION SYSTEMS AND KITS THEREOF   726
US20100009386 METHODS OF IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF LUNG DISEASES AND KITS THEREOF  
The invention provides biomarkers and combinations of biomarkers that are useful in diagnosing lung diseases such as non-small cell lung cancer or reactive airway disease. The invention also...
705
US20140378425 BIOMARKERS FOR DIAGNOSIS OF LUNG DISEASES AND METHODS OF USE THEREOF  
The present disclosure provides methods for diagnosis of interstitial lung diseases (ILDs). The present disclosure provides methods for differential diagnosis of idiopathic pulmonary fibrosis from...
703
US20140309123 METHODS FOR LUNG CANCER CLASSIFICATION  
The present invention provides specific nucleic acid sequences for use in the identification, classification and diagnosis of various sub-types of lung cancers. The present invention permits one...
697
US20120302455 METHODS OF IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF LUNG DISEASES AND KITS THEREOF  
The invention provides biomarkers and combinations of biomarkers useful in diagnosing lung diseases such as non-small cell lung cancer or reactive airway disease. The invention also provides...
677
WO/2014/144564A2 BIOMARKERS FOR DIAGNOSIS OF LUNG DISEASES AND METHODS OF USE THEREOF  
The present disclosure provides methods for diagnosis of interstitial lung diseases (ILDs). The present disclosure provides methods for differential diagnosis of idiopathic pulmonary fibrosis from...
660
8735074 MiRNA biomarkers of lung disease  
This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other...
651
EP3190191A1 METHOD AND KIT FOR THE DIAGNOSIS OF LUNG CANCER  
The present invention refers to the field of cancer and, in particular, to an in vitro method for the diagnosis of lung cancer by determining in a biologicla sample, taken from a subject, the...
645
EP2775300A2 miRNA Biomarkers of Lung Disease  
miRNAs may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis,...
638
WO/2015/018964A1 METHOD FOR CLASSIFICATION, DIAGNOSIS AND MONITORING OF INDIVIDUALS AT RISK OF SUFFERING FROM LUNG CANCER BY MEANS OF SWEAT ANALYSIS  
The invention relates to a method for obtaining useful data for classification, diagnosis and monitoring of lung cancer. The invention also relates to a kit for classification, diagnosis and...
631
WO/2017/042418A1 BIOMARKERS IN EXHALED AIR FOR THE DIAGNOSIS, CLASSIFICATION AND MONITORING OF LUNG CANCER  
The invention relates to a method for obtaining data that can be used for the diagnosis, classification and monitoring of lung cancer, to a kit or device, and to the use thereof.
625
US20110053158 MIRNA BIOMARKERS OF LUNG DISEASE  
This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other...
624
9297805 Compositions, methods and kits for diagnosis of lung cancer  
The present invention provides methods for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a...
618
EP2857522A2 Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy  
The invention provides biomarkers and combinations of biomarkers useful in diagnosing lung diseases such as non-small cell lung cancer or reactive airway disease. The invention also provides...
617
US20140274791 miRNA BIOMARKERS OF LUNG DISEASE  
This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other...
615
9588127 Compositions, methods and kits for diagnosis of lung cancer  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
614
WO/2017/121712A1 METHOD AND KIT FOR THE DIAGNOSIS OF LUNG CANCER  
The present invention refers to the field of cancer and, in particular, to an in vitro method for the diagnosis of lung cancer by determining in a biological sample, taken from a subject, the...
613
9201044 Compositions, methods and kits for diagnosis of lung cancer  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
613
9304137 Compositions, methods and kits for diagnosis of lung cancer  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
603
8637232 Biomarkers for lung disease monitoring  
The present invention pertains to the monitoring and treatment of lung transplant recipients. In particular, the invention pertains to the use of biomarkers to predict or detect post-lung...
603
US20150031065 COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER  
The present invention provides methods for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a...
595
US20170168058 COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
594
US20160161493 Compositions, Methods and Kits for Diagnosis of Lung Cancer  
The present invention provides methods for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a...
592
US20150087728 COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
589
US20160047820 COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
589
7807392 Lung disease targets and uses thereof  
The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic...
588
WO/2011/025919A1 MIRNA BIOMARKERS OF LUNG DISEASE  
This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other...
586
7521195 Lung disease targets and uses thereof  
The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic...
586
US20130217057 Compositions, Methods and Kits for Diagnosis of Lung Cancer  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
584
WO/2010/105235A2 METHODS OF IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF LUNG DISEASES AND KITS THEREOF INCLUDING GENDER-BASED DISEASE IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY  
The invention provides biomarkers and combinations of biomarkers useful in diagnosing lung diseases such as non-small cell lung cancer or reactive airway disease. The invention also provides...
579
US20130230877 Compositions, Methods and Kits for Diagnosis of Lung Cancer  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
578
WO/2015/187612A1 METHOD AND SYSTEMS FOR LUNG CANCER DIAGNOSIS  
The present invention relates to methods and systems for high risk screening, diagnosis, prognosis, and surveillance of lung cancer. Accordingly, in one aspect, the invention provides a method for...
575
WO/2014/100717A2 COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
573
WO/2013/096845A2 COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
572
WO/2003/029273A2 CLASSIFICATION OF LUNG CARCINOMAS USING GENE EXPRESSION ANALYSIS  
The invention provides a molecular taxonomy of lung carcinoma, the leading cause of cancer death in the United States and worldwide. Oligonucleotide micro arrays were used to analyze mRNA...
572
WO/2015/042454A1 COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
571
EP2691545B1 METHODS FOR LUNG CANCER CLASSIFICATION   570
US20040009489 Classification of lung carcinomas using gene expression analysis  
The invention provides a molecular taxonomy of lung carcinoma, the leading cause of cancer death in the United States and worldwide. Oligonucleotide microarrays were used to analyze mRNA...
569
US20110212085 LUNG CANCER DISEASE TARGETS AND USES THEREOF  
The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic...
568
WO/2015/013654A1 COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER  
The present invention provides methods for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a...
568
US20090232822 LUNG DISEASE TARGETS AND USES THEREOF  
The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic...
567
US20110219464 LUNG DISEASE TARGETS AND USES THEREOF  
The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic...
564
JP2016006426A METHODS OF IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF LUNG DISEASES AND KITS THEREOF INCLUDING IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF DISEASES BASED ON GENDER  
PROBLEM TO BE SOLVED: To provide a biomarker useful in diagnosing lung diseases such as non-small cell lung cancer or reactive airway disease, a combination of the biomarkers, a method of...
554
US20160169900 COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER  
Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung...
553
US20110136140 DIAGNOSIS OF SYSTEMIC DISEASES  
It has been found that the pattern of recognized topo I epitopes is different between dcSSc, IcSSc and SLE patients. Fragment F4 (amino acid (AA) 450-600) was recognized by all patients tested....
551

Search
« search again